Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Physiology and Behavior

• Publication date

  2012-12-05

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.physbeh.2012.06.023PMID 22776623PMCID PMC4597915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• (S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD).

  2010influential reference
• P.2.a.002 The potential of the nicotinic channel blocker tc-5214 as augmentation treatment in patients with major depression

  2010cited by this paper
• The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

  2010cited by this paper
• Differential Pharmacologies of Mecamylamine Enantiomers: Positive Allosteric Modulation and Noncompetitive Inhibition

  2009cited by this paper
• Nicotinic Antagonist Augmentation of Selective Serotonin Reuptake Inhibitor-Refractory Major Depressive Disorder: A Preliminary Study

  2008cited by this paper
• TC‐5214 (S‐(+)‐Mecamylamine): A Neuronal Nicotinic Receptor Modulator with Antidepressant Activity

  2008cited by this paper
• Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis.

  2007cited by this paper
• Phasic dysfunction of dopamine transmission in Tourette's syndrome evaluated with 99mTc TRODAT-1 imaging.

  2007cited by this paper
• Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults

  2006cited by this paper
• Treatment of Children and Adolescents With Tics and Tourette Syndrome

  2006cited by this paper
• Acute tolerance to the locomotor stimulant effects of nicotine in the rat

  2005cited by this paper
• Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions.

  2005cited by this paper
• Experiential influences on catalepsy

  2004cited by this paper
• Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors.

  2004cited by this paper
• Parametric influences on catalepsy

  2004cited by this paper
• The effects of nicotine on locomotor behavior in non-tolerant rats: a multivariate assessment

  2004cited by this paper
• Neuroleptic-induced emotional defecation: effects of scopolamine and haloperidol

  2004cited by this paper
• Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome

  2004cited by this paper
• Nicotinic acetylcholine receptors as targets for antidepressants

  2002cited by this paper
• Anxiolytic effects of mecamylamine in two animal models of anxiety.

  2002cited by this paper
• Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamine

  2002cited by this paper
• Corticosterone-attenuating and anxiolytic properties of mecamylamine in the rat

  2001cited by this paper
• Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns?

  2001cited by this paper
• Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes.

  2001cited by this paper
• Mecamylamine Effects on Haloperidol-Induced Catalepsy and Defecation

  2001cited by this paper
• Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.

  2001cited by this paper
• Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder.

  2001cited by this paper
• Nicotine induced seizures blocked by mecamylamine and its stereoisomers.

  2001cited by this paper
• Mecamylamine: new therapeutic uses and toxicity/risk profile.

  2001cited by this paper
• Tourette syndrome, associated conditions and the complexities of treatment.

  2000cited by this paper
• Nicotinic Therapeutics for Tourette Syndrome and Other Neuropsychiatric Disorders

  2000cited by this paper
• Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine).

  2000cited by this paper
• New approaches to the treatment of refractory depression.

  2000cited by this paper
• Mecamylamine in Tourette's Syndrome: A Two-Year Retrospective Case Study

  2000cited by this paper
• Clinical Experience With Transdermal Nicotine Patch in Tourette Syndrome

  1999cited by this paper
• A Nicotine Antagonist, Mecamylamine, Reduces Cue-Induced Cocaine Craving in Cocaine-Dependent Subjects

  1999cited by this paper
• Locomotor behavioral effects of prenatal and postnatal nicotine exposure in rat offspring.

  1999cited by this paper
• Treatment of Tourette's syndrome with mecamylamine.

  1998cited by this paper
• D2-like dopamine receptor density in Tourette syndrome measured by PET.

  1997cited by this paper
• The course and prognosis of Tourette syndrome.

  1997cited by this paper
• Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine.

  1997cited by this paper
• Nicotine for the treatment of Tourette's syndrome.

  1997cited by this paper
• Regulation by nicotine of its own receptors

  1996cited by this paper
• Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment.

  1996cited by this paper
• Transdermal nicotine for Tourette's syndrome

  1996cited by this paper
• Are nicotinic receptors activated or inhibited following chronic nicotine treatment?

  1996cited by this paper
• Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome.

  1996cited by this paper
• Nicotine Blocks Kainic Acid-Induced Wet Dog Shakes in Rats

  1995cited by this paper
• (-)-nicotine protects against systemic kainic acid-induced excitotoxic effects.

  1995cited by this paper
• Transdermal Nicotine in Tourette’s Syndrome

  1995cited by this paper
• Nicotine enhances Morris water maze performance of young and aged rats.

  1995cited by this paper
• Nicotine enhances the learning and memory of aged rats.

  1995cited by this paper
• Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.

  1995cited by this paper
• Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

  1994cited by this paper
• Longlasting improvement of Tourette's syndrome with transdermal nicotine.

  1994cited by this paper
• Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.

  1993cited by this paper
• Allosteric modulations of the nicotinic acetylcholine receptor.

  1993cited by this paper
• Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus

  1993cited by this paper
• The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine.

  1993cited by this paper
• Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome.

  1993cited by this paper
• The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder.

  1992cited by this paper
• Nicotine potentiates the behavioral effects of haloperidol.

  1991cited by this paper
• Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder.

  1991cited by this paper
• Nicotine potentiates haloperidol-induced catalepsy and locomotor hypoactivity.

  1991cited by this paper
• Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine.

  1990cited by this paper
• Underrecognized and underresearched side effects of neuroleptics.

  1989cited by this paper
• Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders.

  1989cited by this paper
• Neuroleptic-induced emotional defecation: effects of pimozide and apomorphine.

  1989cited by this paper
• Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome.

  1989cited by this paper
• Mecamylamine increases nicotine preference and attenuates nicotine discrimination.

  1989cited by this paper
• Desensitization of the nicotinic acetylcholine receptor: Molecular mechanisms and effect of modulators

  1989cited by this paper
• Nicotine gum and haloperidol in Tourette's syndrome.

  1988cited by this paper
• D1- and D2-receptor antagonist induce catalepsy via different efferent. Striatal pathways

  1988cited by this paper
• D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].

  1988cited by this paper
• Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.

  1988cited by this paper
• The catalepsy test: its ups and downs.

  1988cited by this paper
• A controlled study of Tourette syndrome. IV. Obsessions, compulsions, and schizoid behaviors.

  1987cited by this paper
• Clinical Pharmacokinetics of Nicotine

  1987cited by this paper
• A controlled study of Tourette syndrome. V. Depression and mania.

  1987cited by this paper
• The topography of amphetamine and scopolamine-induced hyperactivity: toward an activity print.

  1987cited by this paper
• Gilles de la Tourette's syndrome and attention deficit disorder with hyperactivity. Evidence against a genetic relationship.

  1986cited by this paper
• Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin.

  1986cited by this paper
• Electrophysiological actions of nicotine on substantia nigra single units

  1985cited by this paper
• The role of the GABA mechanisms of the globus pallidus in mediating catalepsy, stereotypy and locomotor activity.

  1984cited by this paper
• Dopaminergic and cholinergic influences on motor behavior in chickens.

  1983cited by this paper
• Kainic acid injections in the striatum alter the cataleptic and locomotor effects of drugs influencing dopaminergic and cholinergic systems.

  1981cited by this paper
• Experimental influences on catalepsy.

  1980cited by this paper
• Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors

  1980cited by this paper
• Acetylcholine and Depression*

  1974cited by this paper
• Cholinergic-adrenergic hypothesis of mania and depression.

  1972cited by this paper
• A cholinergic-adrenergic hypothesis of mania and depression.

  1972cited by this paper
• POISONS INFORMATION SERVICE.

  1965cited by this paper

• THE NEVER LOST: FINDING INVENTORS AMONG OUR STUDENTS AND TRAINEES

  2025cites this paper
• Nicotinic acetylcholine receptors in neurological and psychiatric diseases.

  2023cites this paper
• The boundlessness of behavioral neuroscience: A look across 30 years.

  2022cites this paper
• Efficacy of nicotine administration on obsessions and compulsions in OCD: a systematic review

  2020cites this paper
• Gilles de la Tourette syndrome: an update on the treatment of paediatric patients

  2019cites this paper
• Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

  2018cites this paper
• Mecamylamine treatment for alcohol dependence: a randomized controlled trial

  2018cites this paper
• Chronic Nicotine Mitigates Aberrant Inhibitory Motor Learning Induced by Motor Experience under Dopamine Deficiency

  2016cites this paper
• The effects of lobeline on depression-like behavior and hippocampal cell proliferation following chronic stress in mice.

  2015cites this paper
• Effects of lobeline and reboxetine, fluoxetine, or bupropion combination on depression-like behaviors in mice.

  2015cites this paper
• Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

  2014cites this paper
• The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice

  2014cites this paper